Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin
- PMID: 9419974
- DOI: 10.1038/sj.onc.1201462
Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin
Abstract
Signal transduction by beta-catenin involves its posttranslational stabilization and import to the nucleus where it interacts with transcription factors. Recent implications for beta-catenin signaling in cancer prompted us to examine colon cancer cell lines for the expression of LEF-1, a transcription factor that binds to beta-catenin. The analysis of several cell lines revealed the expression of LEF1 mRNA and a constitutive association of the LEF-1 protein with beta-catenin. In contrast to the colon cells, PC12 and 293 cells did not contain a beta-catenin-LEF-1 complex, even though both proteins were detected in cell lysates. In these cells, the association of endogenous LEF1 and beta-catenin was induced by stimulation with the wnt-1 proto-oncogene. The complex formed following transient stimulation with wnt-1 and also persisted in cells stably expressing wnt-1. Ectopic overexpression of beta-catenin in 293 cells also induced the assembly of the beta-catenin-LEF-1 complex and activated gene transcription from a LEF-1-dependent promotor. Expression of mutant oncogenic forms of beta-catenin identified in cancer cells resulted in higher levels of transcriptional activity. The results suggest that a cancer pathway driven by wnt-1, or mutant forms of beta-catenin, may involve the formation of a persistent transcriptionally active complex of beta-catenin and LEF1.
Similar articles
-
Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.Biochem Biophys Res Commun. 2001 Oct 19;288(1):8-15. doi: 10.1006/bbrc.2001.5719. Biochem Biophys Res Commun. 2001. PMID: 11594745
-
Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.Cancer Res. 2001 Jan 1;61(1):278-84. Cancer Res. 2001. PMID: 11196175
-
WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.Biochem Biophys Res Commun. 1998 Jun 29;247(3):851-8. doi: 10.1006/bbrc.1998.8888. Biochem Biophys Res Commun. 1998. PMID: 9647782
-
[beta-catenin].Nihon Rinsho. 2001 Oct;59 Suppl 6:161-6. Nihon Rinsho. 2001. PMID: 11761935 Review. Japanese. No abstract available.
-
A possible role for the WNT-1 pathway in oral carcinogenesis.Crit Rev Oral Biol Med. 2001;12(2):152-65. doi: 10.1177/10454411010120020501. Crit Rev Oral Biol Med. 2001. PMID: 11345525 Review.
Cited by
-
HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.Nucleic Acids Res. 2003 May 1;31(9):2369-80. doi: 10.1093/nar/gkg346. Nucleic Acids Res. 2003. PMID: 12711682 Free PMC article.
-
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression.Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4262-6. doi: 10.1073/pnas.060025397. Proc Natl Acad Sci U S A. 2000. PMID: 10759547 Free PMC article.
-
Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):139-44. doi: 10.1073/pnas.96.1.139. Proc Natl Acad Sci U S A. 1999. PMID: 9874785 Free PMC article.
-
Regulation of Wnt/β-catenin signaling by herpesviruses.World J Virol. 2016 Nov 12;5(4):144-154. doi: 10.5501/wjv.v5.i4.144. World J Virol. 2016. PMID: 27878101 Free PMC article. Review.
-
Understanding and Targeting the Wnt/β-Catenin Signaling Pathway in Chronic Leukemia.Leuk Res Treatment. 2011;2011:329572. doi: 10.4061/2011/329572. Epub 2011 Dec 4. Leuk Res Treatment. 2011. PMID: 23213540 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous